Literature DB >> 27918380

Genetic Susceptibility to Norovirus GII.4 Sydney Strain Infections in Taiwanese Children.

Li-Tzu Tu1, Fu-Ping Liu, Yhu-Chering Huang, Chung-Guei Huang, Shuan Yang, Kuo-Chien Tsao, Ming-Wei Lai, Chih-Jung Chen.   

Abstract

BACKGROUND: A comprehensive evaluation of associations between the susceptibility to norovirus infections and histo-blood group antigens is not available in the Taiwanese population, in which the nonsecretor phenotype is absent.
METHODS: A 1:1 matched case-control study was conducted in northern Taiwan from February 2013 to December 2014 when an epidemic of norovirus infection occurred. Cases were children <18 years old who were hospitalized because of diarrhea and were found to have laboratory-confirmed norovirus infections. Controls were healthy children matched to the cases by age and gender. The norovirus genotype was determined by polymerase chain reaction sequencing of the VP1 gene. The secretor status, Lewis antigen and ABO type were determined by characterization of genetic polymorphisms in the FUT2, FUT3 and ABO genes, respectively.
RESULTS: A total of 147 case-control pairs were included. GII.4 Sydney strain was the major genotype and identified in 78.3% of the cases. The weak-secretor and Lewis-positive genotypes were less commonly identified in cases than in controls (5.4% vs. 23.1% and 79.6% vs. 89.8%, respectively). Multivariate analysis revealed that the secretor and Lewis-negative genotypes were both independent factors associated with increased risk of norovirus infections [matched odds ratio: 6.766, 95% confidence interval (CI): 2.649-17.285, P < 0.0001 and matched odds ratio: 3.071, 95% confidence interval [CI]: 1.322-7.084, P = 0.0085, respectively]. The ABO types were not significantly related to norovirus infections (P > 0.05).
CONCLUSION: The weak-secretor genotype and the Lewis antigen-positive genotype were both protective factors against severe norovirus gastroenteritis during the GII.4 Sydney strain epidemic in Taiwan.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27918380     DOI: 10.1097/INF.0000000000001446

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  6 in total

1.  Norovirus in health care and implications for the immunocompromised host.

Authors:  Pearlie P Chong; Robert L Atmar
Journal:  Curr Opin Infect Dis       Date:  2019-08       Impact factor: 4.915

Review 2.  Epidemiology and evolution of Norovirus in China.

Authors:  Na Wei; Jun Ge; Changyao Tan; Yunlong Song; Shiwei Wang; Mengru Bao; Jianqiang Li
Journal:  Hum Vaccin Immunother       Date:  2021-09-08       Impact factor: 4.526

Review 3.  Human Genetic Determinants of Viral Diseases.

Authors:  Adam D Kenney; James A Dowdle; Leonia Bozzacco; Temet M McMichael; Corine St Gelais; Amanda R Panfil; Yan Sun; Larry S Schlesinger; Matthew Z Anderson; Patrick L Green; Carolina B López; Brad R Rosenberg; Li Wu; Jacob S Yount
Journal:  Annu Rev Genet       Date:  2017-08-30       Impact factor: 16.830

4.  Population-Level Human Secretor Status Is Associated With Genogroup 2 Type 4 Norovirus Predominance.

Authors:  Cory J Arrouzet; Karen Ellis; Anita Kambhampati; Yingxi Chen; Molly Steele; Ben Lopman
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

5.  Genetic Susceptibility to Rotavirus Gastroenteritis and Vaccine Effectiveness in Taiwanese Children.

Authors:  Ting-An Yang; Ju-Yin Hou; Yhu-Chering Huang; Chih-Jung Chen
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

6.  FUT2, Secretor Status and FUT3 Polymorphisms of Children with Acute Diarrhea Infected with Rotavirus and Norovirus in Brazil.

Authors:  Marco André Loureiro Tonini; Débora Maria Pires Gonçalves Barreira; Luciana Bueno de Freitas Santolin; Lays Paula Bondi Volpini; José Paulo Gagliardi Leite; Béatrice Le Moullac-Vaidye; Jacques Le Pendu; Liliana Cruz Spano
Journal:  Viruses       Date:  2020-09-25       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.